Closed consultation

Availability of diclofenac as a pharmacy medicine (MLX 382)

From:
Medicines and Healthcare products Regulatory Agency
Published
5 August 2013

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

The MHRA is undertaking a public consultation on the continued availability of diclofenac as a Pharmacy (P) medicine.

This consultation ran from
to

Consultation description

The MHRA is undertaking a public consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and in particular on risk minimisation measures advised by the Commission on Human Medicines.

Comments must arrive no later than 28 October 2013. Comments received after this date will not be taken into account.

Documents

Availability of diclofenac as a pharmacy medicine

PDF, 79.5 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Published 5 August 2013